Industry News
Australian Synchrotron to continue world leading research
Australian researchers will continue to undertake vital research - in areas such as health, manufacturing and food security - in Australia thanks to a new program to manage researcher access to the Australian Synchrotron. [ + ]
Sunflower seed drug discovery earns national award
The discovery that a cancer drug is hiding in sunflower seeds has won a University of Queensland (UQ) plant scientist a national award. [ + ]
Young LEI researcher wins international backing for glaucoma research
Lions Eye Institute (LEI) researcher Alex Hewitt is one of eight international recipients of a prestigious 2012 Alcon Research Institute (ARI) Young Investigator Grant. The grant is worth $50,000 and will allow Dr Hewitt to further his research into glaucoma genetics. [ + ]
Funding for AIBN and DSM collaboration; a step towards smart new medicines
An international collaboration involving the development of the next generation of smart medicines in Brisbane has received a boost, with more than $1 million in state government funding. [ + ]
STA to bring new CDI treatment to A/NZ
Specialised Therapeutics Australia (STA) has secured a deal to launch a new therapy for the colostrum difficile “superbug” in Australia and New Zealand. [ + ]
Spotlight on women in science, maths and engineering
Providing opportunities for women in science is crucial to ensure the future productivity and global competitiveness of the country, the Minister for Science and Research, Senator Chris Evans, told a newly created bipartisan support group at an event on 20 June. [ + ]
Curtin medal for a Nobel professor
Nobel Laureate and molecular biologist Professor Elizabeth Blackburn was awarded the Curtin Medal for Excellence in Medical Research at The Australian National University this morning. [ + ]
TenasiTech trifecta: industry, investment and government support
TenasiTech, a materials science start-up company from UniQuest, based on University of Queensland research, has secured $1.4 million in grants and equity capital from the Queensland Government and Uniseed. [ + ]
Market moves: CSL buyback hits $600m
CSL (ASX:CSL) has now repurchased close to $600 million worth of its own shares, under a buyback program which commenced in October last year. [ + ]
Mayne clears hurdle to SUBACAP approval in EU
Mayne Pharma (ASX:MYX) is back on track to gaining marketing approval from the EMA for its SUBACAP fungal infection treatment, after its application was temporarily derailed by UK regulators. [ + ]
World’s top agbiotech conference to visit Down Under
The world’s leading agricultural biotechnology event, ABIC (Agricultural Biotechnology International Conference) 2012, is coming to our region in September with the annual event to be held in Rotorua, New Zealand, and hosted by NZBIO with the support of AusBiotech. [ + ]
Virus traces in Fluvax blamed for risk in children
CSL (ASX:CSL) unit CSL Biotherapies has tentatively blamed the particulars of the manufacturing process for the adverse reactions to its Fluvax influenza vaccine in some young children in 2010. [ + ]
Awards support the future of agricultural science
Dr Matt Cahill, Dow AgroSciences Research and Development Leader for Australia and New Zealand, and the Hon Sid Sidebottom, Parliamentary Secretary for Agriculture, Fisheries and Forestry, have recognised the work of promising students and inspirational teachers in the primary industries sector with the presentation of annual awards. [ + ]
Stem cell research gains momentum in Queensland
Stem Cells Ltd, based at the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland, is set to receive $470,000 in Queensland Government science funding to advance cutting-edge stem cell research into diseases such as schizophrenia, Down syndrome, Parkinson’s disease and heart disease. [ + ]
BIO 2012 biotech profile: Bionomics
Bionomics recently captured headlines with its spectacular deal with Ironwood Pharmaceuticals for its anti-anxiety compound, BNC210. But the South Australian biotech has even more tricks up its sleeve. [ + ]